The CFO & Treasurer of 22nd Century (NYSE MKT: XXII) is Buying Shares

By George MacDonald

Yesterday, the CFO & Treasurer of 22nd Century (NYSE MKT: XXII), John Brodfuehrer, bought shares of XXII for $9,500.

John Brodfuehrer increased his holding by 5%.

Based on 22nd Century`s latest earnings report from December 31, the company posted quarterly revenue of $2.93M and GAAP net loss of $2.86M. In comparison, last year the company earned revenue of $911 and had a GAAP net loss of $5.59M. Currently, 22nd Century has an average volume of 352.7k. The company has a one year high of $1.75 and a one year low of $0.56.

Starting in January 2014, XXII received 4 Buy ratings in a row.

Looking at blogger coverage of XXII, there is a 75% Bearish tendency on the stock, in relation to an 80% average bullish tendency within the Healthcare sector.

22nd Century Group, Inc. is a plant biotechnology company. Its proprietary technology allows for the levels of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. The company operates its business through smoking cessation products and modified risk tobacco products segments. Its subsidiary Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes; and Hercules Pharmaceuticals LLC is focused on X-22, a prescription smoking cessation aid in development. 22nd Century Group’s business roots are back to February 20, 1998. The company was founded by Joseph pandolfino on September 12, 2005 and is headquartered in Clarence, NY.